Bendamustine

CAS No. 16506-27-7

Bendamustine( SDX105 )

Catalog No. M21612 CAS No. 16506-27-7

Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 82 In Stock
2MG 43 In Stock
5MG 68 In Stock
10MG 116 In Stock
25MG 258 In Stock
50MG 398 In Stock
100MG 594 In Stock
200MG Get Quote In Stock
500MG 1274 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bendamustine
  • Note
    Research use only, not for human use.
  • Brief Description
    Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
  • Description
    Bendamustine for the treatment of Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    SDX105
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    cancer
  • Indication
    Hodgkin's Disease Lymphoma

Chemical Information

  • CAS Number
    16506-27-7
  • Formula Weight
    358.26
  • Molecular Formula
    C16H21Cl2N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:72 mg/mL (200.97 mM)
  • SMILES
    Cn1c(CCCC(O)=O)nc2cc(ccc12)N(CCCl)CCCl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Patekar M B Milunovi V Jakobac K M et al. Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia[J]. Acta Clinica Croatica 2018 57(3):542-553.
molnova catalog
related products
  • (Tyr1)-Delta-Sleep I...

    (Tyr1)-Delta-Sleep Inducing Peptide

  • Pueroside B

    Pueroside B may can treat coronary heart disease, it can interact with two or more targets[peroxisome proliferator activated receptor γ (PPAR-γ), angiotensin-converting enzyme (ACE), hydroxymethylglutaryl coenzyme A receptor (HMGR), cyclooxygenase-2 (COX2), and thrombin].

  • Bromosporine

    Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.